Quarterly report · Q3
9776.TEDINET S100SUF0
Period2023-04-01 → 2023-12-31
Filed2024-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥14.9bn | 2023-04-01 → 2023-12-31 | Cons. | Net sales |
| Revenue | ¥20.1bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥15.3bn | 2022-04-01 → 2022-12-31 | Cons. | Net sales |
| Operating income | ¥415m | 2023-04-01 → 2023-12-31 | Cons. | Operating income |
| Operating income | ¥817m | 2022-04-01 → 2022-12-31 | Cons. | Operating income |
| Ordinary income | ¥418m | 2023-04-01 → 2023-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.2bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥972m | 2022-04-01 → 2022-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥508m | 2023-04-01 → 2023-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥891m | 2022-04-01 → 2022-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥312m | 2023-04-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥569m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥493m | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥305m | 2023-04-01 → 2023-12-31 | Cons. | Profit loss |
| Net income | ¥578m | 2022-04-01 → 2022-12-31 | Cons. | Profit loss |
| Total assets | ¥16.9bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥16.5bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥16.9bn | at 2022-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥5.8bn | at 2023-12-31 | Cons. | Liabilities |
| Total liabilities | ¥5.6bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥11.1bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥10.9bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥10.8bn | at 2022-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥4.0bn | at 2023-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.7bn | at 2023-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥93.67 | 2023-04-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥25.72 | 2023-10-01 → 2023-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥170.53 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥147.85 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥70.53 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 64.0% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 64.1% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.2% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2023-12-31 | ¥92m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2023-12-31 | ¥90m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥3m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-12-31 | ¥66m |
| jpcrp040300-q3r_E04950-000Clinical Testing Businessreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥5.8bn |
| jpcrp040300-q3r_E04950-000Clinical Testing Businessreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥5.8bn |
| jpcrp040300-q3r_E04950-000Clinical Testing Businessreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥104m |
| jpcrp040300-q3r_E04950-000Dispensing Pharmacy Businessreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥8.3bn |
| jpcrp040300-q3r_E04950-000Dispensing Pharmacy Businessreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥8.3bn |
| jpcrp040300-q3r_E04950-000Dispensing Pharmacy Businessreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥548m |
| jpcrp040300-q3r_E04950-000Medical Devices And Maintenance Businessreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥1.2bn |
| jpcrp040300-q3r_E04950-000Medical Devices And Maintenance Businessreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥722m |
| jpcrp040300-q3r_E04950-000Medical Devices And Maintenance Businessreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥477m |
| jpcrp040300-q3r_E04950-000Medical Devices And Maintenance Businessreportable segment | segment profit | 2023-04-01 → 2023-12-31 | −¥7m |
| —segment total | revenue | 2023-04-01 → 2023-12-31 | ¥15.2bn |
| —segment total | revenue external | 2023-04-01 → 2023-12-31 | ¥14.8bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥477m |
| —segment total | segment profit | 2023-04-01 → 2023-12-31 | ¥645m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-12-31 | ¥15.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-12-31 | ¥14.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥480m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-12-31 | ¥711m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-12-31 | ¥75m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-12-31 | ¥73m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥3m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-12-31 | ¥49m |
| jpcrp040300-q3r_E04950-000Clinical Testing Businessreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥6.4bn |
| jpcrp040300-q3r_E04950-000Clinical Testing Businessreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥6.4bn |
| jpcrp040300-q3r_E04950-000Clinical Testing Businessreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥532m |
| jpcrp040300-q3r_E04950-000Dispensing Pharmacy Businessreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥8.0bn |
| jpcrp040300-q3r_E04950-000Dispensing Pharmacy Businessreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥8.0bn |
| jpcrp040300-q3r_E04950-000Dispensing Pharmacy Businessreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥601m |
| jpcrp040300-q3r_E04950-000Medical Devices And Maintenance Businessreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥1.2bn |
| jpcrp040300-q3r_E04950-000Medical Devices And Maintenance Businessreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥726m |
| jpcrp040300-q3r_E04950-000Medical Devices And Maintenance Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥495m |
| jpcrp040300-q3r_E04950-000Medical Devices And Maintenance Businessreportable segment | segment profit | 2022-04-01 → 2022-12-31 | −¥8m |
| —segment total | revenue | 2022-04-01 → 2022-12-31 | ¥15.7bn |
| —segment total | revenue external | 2022-04-01 → 2022-12-31 | ¥15.2bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥495m |
| —segment total | segment profit | 2022-04-01 → 2022-12-31 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-12-31 | ¥15.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-12-31 | ¥15.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥498m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-12-31 | ¥1.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 389
| Item | Context | Value | Unit |
|---|---|---|---|
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 885400 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.2100 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 885400 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 885400 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.2100 | |
| Cash and deposits | Prior1YearInstant | 3664081000 | JPY |
| Cash and deposits | CurrentQuarterInstant | 3986995000 | JPY |
| Notes and accounts receivable trade and contract assets | Prior1YearInstant | 2947145000 | JPY |
| Notes and accounts receivable trade and contract assets | CurrentQuarterInstant | 2975856000 | JPY |
| Merchandise and finished goods | Prior1YearInstant | 431748000 | JPY |
| Merchandise and finished goods | CurrentQuarterInstant | 640270000 | JPY |
| Work in process | Prior1YearInstant | 20215000 | JPY |
| Work in process | CurrentQuarterInstant | 10816000 | JPY |
| Raw materials and supplies | Prior1YearInstant | 62760000 | JPY |
| Raw materials and supplies | CurrentQuarterInstant | 79946000 | JPY |
| Other ca | Prior1YearInstant | 208453000 | JPY |
| Other ca | CurrentQuarterInstant | 207790000 | JPY |
| Allowance for doubtful accounts ca | Prior1YearInstant | -23519000 | JPY |
| Allowance for doubtful accounts ca | CurrentQuarterInstant | -22135000 | JPY |
| Current assets | Prior1YearInstant | 7310885000 | JPY |
| Current assets | CurrentQuarterInstant | 7879540000 | JPY |
| Buildings and structures | Prior1YearInstant | 4442450000 | JPY |
| Buildings and structures | CurrentQuarterInstant | 4495385000 | JPY |
| Accumulated depreciation buildings and structures | Prior1YearInstant | -992174000 | JPY |
| Accumulated depreciation buildings and structures | CurrentQuarterInstant | -1090343000 | JPY |
| Buildings and structures net | Prior1YearInstant | 3450275000 | JPY |
| Buildings and structures net | CurrentQuarterInstant | 3405041000 | JPY |
| Machinery equipment and vehicles | Prior1YearInstant | 24659000 | JPY |
| Machinery equipment and vehicles | CurrentQuarterInstant | 26032000 | JPY |
| Accumulated depreciation machinery equipment and vehicles | Prior1YearInstant | -21776000 | JPY |
| Accumulated depreciation machinery equipment and vehicles | CurrentQuarterInstant | -20850000 | JPY |
| Machinery equipment and vehicles net | Prior1YearInstant | 2883000 | JPY |
| Machinery equipment and vehicles net | CurrentQuarterInstant | 5182000 | JPY |
| Tools furniture and fixtures | Prior1YearInstant | 2394117000 | JPY |
| Tools furniture and fixtures | CurrentQuarterInstant | 2422547000 | JPY |
| Accumulated depreciation tools furniture and fixtures | Prior1YearInstant | -1867410000 | JPY |
| Accumulated depreciation tools furniture and fixtures | CurrentQuarterInstant | -1908581000 | JPY |
| Tools furniture and fixtures net | Prior1YearInstant | 526706000 | JPY |
| Tools furniture and fixtures net | CurrentQuarterInstant | 513966000 | JPY |
| Land | Prior1YearInstant | 3429506000 | JPY |
| Land | CurrentQuarterInstant | 3376552000 | JPY |
| Lease assets ppe | Prior1YearInstant | 782266000 | JPY |
| Lease assets ppe | CurrentQuarterInstant | 791257000 | JPY |
| Accumulated depreciation lease assets ppe | Prior1YearInstant | -160606000 | JPY |
| Accumulated depreciation lease assets ppe | CurrentQuarterInstant | -237159000 | JPY |
| Lease assets net ppe | Prior1YearInstant | 621660000 | JPY |
| Lease assets net ppe | CurrentQuarterInstant | 554098000 | JPY |
| Construction in progress | Prior1YearInstant | 417978000 | JPY |
| Construction in progress | CurrentQuarterInstant | 443041000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |